Detalhe da pesquisa
1.
The second national anti-tuberculosis drug resistance survey in Tanzania, 2017-2018.
Trop Med Int Health
; 27(10): 891-901, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36089572
2.
Implementing tuberculosis patient cost surveys in resource-constrained settings: lessons from Tanzania.
BMC Public Health
; 22(1): 2187, 2022 11 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-36434606
3.
Economic burden of tuberculosis in Tanzania: a national survey of costs faced by tuberculosis-affected households.
BMC Public Health
; 22(1): 600, 2022 03 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-35351063
4.
Isoniazid and Rifampin-Resistance Mutations Associated With Resistance to Second-Line Drugs and With Sputum Culture Conversion.
J Infect Dis
; 221(12): 2072-2082, 2020 06 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32002554
5.
Impact of GeneXpert MTB/RIF® on treatment initiation and outcomes of RIF-resistant and RIF-susceptible TB patients in Vladimir TB dispensary, Russia.
BMC Infect Dis
; 20(1): 543, 2020 Jul 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-32711457
6.
Comparison of Sputum-Culture Conversion for Mycobacterium bovis and M. tuberculosis.
Emerg Infect Dis
; 23(3): 456-462, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28221125
7.
Susceptibilities of MDR Mycobacterium tuberculosis isolates to unconventional drugs compared with their reported pharmacokinetic/pharmacodynamic parameters.
J Antimicrob Chemother
; 72(6): 1678-1687, 2017 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28333192
8.
Multidrug-Resistant Tuberculosis Treatment Outcomes in Relation to Treatment and Initial Versus Acquired Second-Line Drug Resistance.
Clin Infect Dis
; 62(4): 418-430, 2016 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26508515
9.
Evaluation of community-based treatment for drug-resistant tuberculosis in Bangladesh.
Trop Med Int Health
; 21(1): 131-139, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26489698
10.
Epidemiology of Primary Multidrug-Resistant Tuberculosis, Vladimir Region, Russia.
Emerg Infect Dis
; 21(11): 2048-51, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26488585
11.
Risk factors for acquisition of drug resistance during multidrug-resistant tuberculosis treatment, Arkhangelsk Oblast, Russia, 2005-2010.
Emerg Infect Dis
; 21(6): 1002-11, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25988954
12.
Additional drug resistance of multidrug-resistant tuberculosis in patients in 9 countries.
Emerg Infect Dis
; 21(6): 977-83, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25988299
13.
Association between Regimen Composition and Treatment Response in Patients with Multidrug-Resistant Tuberculosis: A Prospective Cohort Study.
PLoS Med
; 12(12): e1001932, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26714320
14.
Mortality among tuberculosis patients with acquired resistance to second-line antituberculosis drugs--United States, 1993-2008.
Clin Infect Dis
; 59(4): 465-72, 2014 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24846639
15.
Extensive drug resistance acquired during treatment of multidrug-resistant tuberculosis.
Clin Infect Dis
; 59(8): 1049-63, 2014 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25057101
16.
Tuberculosis preventive treatment uptake among adults living with human immunodeficiency virus: Analysis of Zimbabwe population-based human immunodeficiency virus impact assessment 2020.
Int J STD AIDS
; : 9564624241239186, 2024 Mar 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38515336
17.
Prevalence of and risk factors for resistance to second-line drugs in people with multidrug-resistant tuberculosis in eight countries: a prospective cohort study.
Lancet
; 380(9851): 1406-17, 2012 Oct 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-22938757
18.
The economic burden of households affected by tuberculosis in Brazil: First national survey results, 2019-2021.
PLoS One
; 18(12): e0287961, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38091306
19.
Acquired resistance to second-line drugs among persons with tuberculosis in the United States.
Clin Infect Dis
; 55(12): 1600-7, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22942206
20.
Pre-treatment loss to follow-up among children with multidrug-resistant tuberculosis in South Africa, 2008-2010.
PLoS One
; 15(4): e0230504, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32255811